Skip to content

Effects of Perioperative Esketamine Administration on Pain Catastrophizing and Chronic Postsurgical Pain in Patients with Traumatic Lower Limb Fractures

Effects of Perioperative Esketamine Administration on Pain Catastrophizing and Chronic Postsurgical Pain in Patients with Traumatic Lower Limb Fractures - Effects of Perioperative Esketamine on Chronic Postsurgical Pain in Patients with Lower Limb Fractures

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106619
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Postsurgical Pain

Interventions

Group C:From the beginning of anesthesia induction until 30 minutes before the end of the surgery, an equivalent amount of saline solution was injected as in Group E. No esketamine was included in the
Group E:Esketamine was administered from anesthesia induction until 30 minutes before the end of surgery. It was also added to the postoperative analgesia pump for supplemental pain control.

Sponsors

Tongling People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA physical status I–II; 2. Aged 18–65 years; 3. BMI: 18–30 kg/m²; 4. Effective communication skills and the capacity to comprehend and independently complete all study scales; 5. Patients with lower extremity fractures involving the distal fem,.ur region (including femoral shaft, patella, tibiofibular and calcaneal fractures) requiring tourniquet use during surgical intervention

Exclusion criteria

Exclusion criteria: 1. Patients with severe organic diseases or chronic pain disorders (e.g., rheumatoid arthritis, rheumatic arthritis); 2. Prior surgical procedures involving lower extremity fracture fixation; 3. Chronic preoperative use of analgesic agents (opioids, NSAIDs, or other pain medications); 4. Any contraindication to esketamine administration including severe hypertension, glaucoma; 5. Patients with severe psychiatric disorders; 6. Excluding metatarsal/phalangeal fractures and external fixation cases.

Design outcomes

Primary

MeasureTime frame
Chronic postsurgical pain;

Secondary

MeasureTime frame
Pain catastrophizing scores;Acute postsurgical pain;Tourniquet reaction;Hospital Anxiety and Depression Scale;plasma IL-6 and CRP;Pain rescue medication;

Countries

China

Contacts

Public ContactTang Ting

Tongling People's Hospital

18756299530@163.com+86 187 5629 9530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026